C

Charles River Associates

Global litigation, regulatory, and financial consulting

Consulting Associate/Recovery Services - Forensic Services practice

Full-Time
CA$120k - CA$140k/yr+ Bonus incentive compensation
Mid
Toronto, ON, Canada
HybridAt least 3 to 4 days a week in the office; may include travel to another CRA office or client meetings.
CybersecuritySecurity Operations & Incident Response

About the job

Requirements
  • Three to five years of hands-on experience in incident response, digital forensics, or a closely related security engineering role.
  • Demonstrated experience responding to ransomware, business email compromise, or intrusion matters in enterprise environments.
  • Deep working knowledge of Active Directory and Entra ID, including attack paths such as Kerberos abuse, shadow credentials, and Active Directory Certificate Services misconfigurations, as well as hardening controls.
  • Proficiency with at least one enterprise endpoint detection and response platform and its response tooling.
  • Strong scripting ability in PowerShell; Python is a plus.
  • Excellent written communication and the ability to produce report-quality prose without heavy editing.
  • Ability to operate independently under incident conditions and manage competing priorities across concurrent matters.
Responsibilities
  • Execute digital forensic collection and analysis across Windows, Linux, virtualized environments (VMware and Hyper-V), and cloud environments (Azure, Microsoft 365, and Google Workspace).
  • Perform endpoint and identity containment using endpoint detection and response platforms such as CrowdStrike Falcon or equivalent, including real-time response, custom detection logic, and telemetry analysis.
  • Lead technical recovery workstreams in ransomware matters, including domain controller rebuild and validation, tiered credential resets, hypervisor and backup restoration, and host checkout against defined gate criteria.
  • Investigate business email compromise and wire fraud matters, including mail flow reconstruction, tenant log analysis, OAuth and enterprise application audits, and attacker infrastructure attribution.
  • Analyze and remediate hybrid identity environments, including Active Directory, Entra ID, Entra Connect, Conditional Access, and privileged access configurations.
  • Develop and maintain PowerShell, Graph SDK, and Python tooling for collection, containment, and recovery automation.
  • Produce clear, defensible written work product, including forensic reports, investigation timelines, containment playbooks, and client status communications.
  • Support engagement scoping by contributing technical level-of-effort estimates grounded in environment evidence.
  • Interface directly with client IT teams, counsel, and carrier representatives during active matters.
Desired Qualifications
  • Industry certifications such as GCFA, GCIH, GNFA, GCFE, EnCE, CISSP, or equivalent.
  • Experience with virtualization forensics, including VMware vSAN, iSCSI, and datastore-level acquisition, and backup platform recovery.
  • Familiarity with Google Workspace forensics and administrative tooling.
  • Experience working under legal privilege with outside counsel and cyber insurance carriers.
  • Exposure to OT/ICS environments or regulated industries such as healthcare and financial services.

About the company

C

Charles River Associates

View

Charles River Associates (CRA) is a global consulting firm that specializes in litigation, regulatory, financial, and management consulting. It provides economic and financial analysis to support litigation and regulatory proceedings, helping clients make informed choices in strategy and operations. Services include expert economic testimony, financial advisory, and custom consulting for corporations, law firms, and government agencies. CRA distinguishes itself through deep functional expertise and industry knowledge applied to complex problems, supported by offices around the world. The firm’s goal is to deliver objective, high-value analysis and advice that helps clients navigate legal, regulatory, and business challenges and improve decision-making and outcomes.

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

City of Brussels, Belgium

Founded

1978

Get referred to Charles River Associates

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Q2 2026 revenue hit $210.8 million, with 12.8% year-over-year growth.
  • CRA raised fiscal 2026 revenue guidance to $805 million-$820 million after record demand.
  • A new $400 million credit facility funds hiring, working capital, and growth investments.

What critics are saying

  • Fiscal 2026 cash from operations turned negative, while net debt reached $197.6 million.
  • Management expects $15 million more forgivable-loan amortization, squeezing margins through 2026.
  • AI tools and intense competition commoditize economic analysis, threatening premium expert-testimony pricing by 2027.

What makes Charles River Associates unique

  • CRA recruits Harvard and Yale economists into antitrust work, deepening expert-testimony credibility.
  • Its antitrust practice spans pricing, merger reviews, digital markets, and China competition matters.
  • Eight practices generated growth in Q2 2026, showing diversified specialist demand.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Wellness Program
  • Flexible Work Hours
  • Remote Work Options
  • Professional Development Budget

Growth & Insights and Company News

6 month growth

5%

1 year growth

6%

2 year growth

6%
Yahoo Finance
Oct 6th, 2026
Charles River Associates appoints Christopher Zealey as VP to expand life sciences practice

Charles River Associates (NASDAQ: CRAI) has appointed Christopher Zealey as Vice President in its Life Sciences Practice. Zealey brings expertise in cross-functional and medical strategic planning, insight generation, scientific communication strategy, and clinical positioning. Before joining CRA, Zealey was a partner at a life sciences and pharmaceutical consulting firm, where he led client engagements across strategic planning, insight generation, and medical intelligence to support product launches. His experience includes leveraging data and stakeholder perspectives to inform strategy. CRA's Life Sciences Practice works with biotech, medical device, and pharmaceutical companies, as well as law firms and regulatory agencies. The firm has been expanding its capabilities to help clients navigate complex medical affairs and launch decisions. Zealey holds an MSc in Biotechnology from McGill University and a BSc in Microbiology from the University of Waterloo.

Associated Press
Oct 1st, 2026
CRA adds Harvard Business School professor to antitrust practice

Charles River Associates has appointed Harvard Business School Professor Feng Zhu as an Academic Affiliate in its Antitrust & Competition Economics Practice. Zhu is the Harry E. Figgie, Jr. Professor of Business Administration at Harvard Business School, where he leads the Platform Lab within the AI Institute and co-chairs the Analytics Programme. His research focuses on digital transformation, competitive strategy, and the strategic behaviour of large technology companies. Zhu has advised global business leaders at firms including Alphabet, Meta, Microsoft, and Uber. Margaret Sanderson, Global Practice Leader of the Antitrust & Competition Economics Practice at CRA, said Zhu's expertise combines academic research with technology business knowledge. He also brings experience in antitrust and competition matters in China.

Yahoo Finance
Aug 15th, 2026
CRA International beats Q2 estimates with $210.8M revenue, driven by double-digit growth in forensic services and AI complexity

CRA International reported second-quarter revenue of $210.8 million and adjusted earnings per share of $2.16, both exceeding analyst expectations. The consulting firm saw 12.8% year-on-year revenue growth driven by double-digit expansion across Energy, Life Sciences, and Forensic Services practices. CEO Paul Maleh noted that eight practices, representing 95% of total revenue, grew year-on-year. Both North American and international operations contributed to the performance. During the earnings call, analysts questioned the sustainability of growth in management consulting and the potential impact of Department of Justice changes to merger reviews. Maleh highlighted historically high conversion rates in Life Sciences and Energy, whilst acknowledging challenges in forecasting from "unprecedented performance peaks". The company's market capitalisation stands at $1.06 billion.

Yahoo Finance
Aug 12th, 2026
CRA International raises revenue outlook but margin pressures and $198M net debt weigh on valuation premium

CRA International reported 12.8% year-over-year revenue growth in Q2, reaching $210.8 million, with management consulting revenues up 25.5%. The firm raised its fiscal 2026 revenue guidance to $805-820 million from $785-805 million, supported by growth across eight practices representing 95% of revenues. However, profitability pressures persist. Cost of services rose to 71.3% of first-half revenues from 67.5% last year, whilst non-GAAP EBITDA margin declined to 12.1% from 13%. Management expects non-cash forgivable-loan amortisation to increase by roughly $15 million in fiscal 2026. First-half operating activities consumed $118.3 million in cash, up from $74.1 million previously. CRAI ended Q2 with $21.4 million cash and $197.6 million net debt. The stock trades at 18.7 times forward earnings, above the consulting sub-industry's 14.6 times multiple.

Yahoo Finance
Aug 10th, 2026
CRAI beats Q2 estimates with $210.8M revenue as demand surges across eight practices

CRA International reported second-quarter revenue of $210.8 million, beating analyst estimates of $198.9 million and marking 12.8% year-on-year growth. The economic consulting firm's adjusted earnings per share of $2.16 also exceeded expectations. The company saw double-digit growth across six practices, including Energy, Life Sciences, and Forensic Services. Antitrust & Competition Economics achieved a quarterly revenue high. International revenues rose 32.9% year-on-year, driven by organic growth. CEO Paul Maleh cited "peak levels of new project opportunities and historically high conversion rates", particularly in Life Sciences and Energy. The company increased consultant headcount by 3.3%, with utilisation reaching 77%. Management attributed demand to rising legal case filings and record merger and acquisition activity, though cautioned that geopolitical and macroeconomic conditions could affect future performance.